EGFR Gene Variants and Lung Cancer Risk
Author Information
Author(s): Choi Jin Eun, Ha Park Sun, Kim Kyung Mee, Lee Won Kee, Kam Sin, Cha Sung Ick, Ho Kim Chang, Mo Kang Young, Kim Young-Chul, Han Sung Beom, Jung Tae Hoon, Park Jae Yong
Primary Institution: Kyungpook National University
Hypothesis
Polymorphisms in the epidermal growth factor receptor (EGFR) gene may influence susceptibility to lung cancer.
Conclusion
The EGFR polymorphisms, particularly the 181946C>T polymorphism, could be used as markers for genetic susceptibility to lung cancer.
Supporting Evidence
- The 181946C>T genotype was associated with a significantly decreased risk of lung cancer.
- The protective effect of the TT genotype was statistically significant in ever-smokers.
- The CGGCT haplotype with the 181946C allele was associated with a significantly increased risk of lung cancer.
Takeaway
Some changes in a gene called EGFR might make people more likely to get lung cancer, especially if they smoke.
Methodology
A case-control study was conducted with 582 lung cancer patients and 582 healthy controls, examining specific polymorphisms in the EGFR gene.
Limitations
The study may have type I and type II errors due to multiple comparisons and small subgroup sizes.
Participant Demographics
Participants included 582 lung cancer patients and 582 healthy controls, all ethnic Koreans from Daegu City.
Statistical Information
P-Value
0.007
Confidence Interval
95% CI = 0.45–0.88
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website